Effects of Air Pollution on Disease Activity and Health-Related Quality of Life of Systemic Lupus Erythematous Patients: An Iranian Observational Longitudinal Study

Page: [222 - 229] Pages: 8

  • * (Excluding Mailing and Handling)

Abstract

Introduction: Air pollution is one of the environmental factors that influences the pathogenesis of systemic autoimmune diseases, followed by the development and spread of inflammation and increased oxidative damage. Only a few studies have been conducted on the impact of air pollution on disease activity in patients with lupus, which mostly have focused on PM2.5 particles.

Materials and Methods: We longitudinally studied 50 patients with lupus bimonthly in a 6-month period in Mashhad, one of the polluted cities of Iran. Disease activity and quality of life were examined considering SLEDAI2K, SLEQOL, and VAS criteria. The outdoor air pollutant was measured by monitoring the average concentration of nitrogen dioxide (NO2), carbon monoxide (CO), some particles less than 10 and 2.5 micrometers in diameter (PM <10, PM <2.5) and the level of temperature and humidity which were taken from the Meteorological Organization of Mashhad. Confounding factors such as medications were investigated by univariate and multivariate statistical analysis, specifically by GEE method.

Results: The possible relation among various factors to SLEDAI, SLEQOL and VAS by two different univariate and multivariate analyses were studied. Our analysis indicated that spring season, decreased temperature, increased air pollutants including (PM2.5, and NO2) and increased humidity increase SLEDAI2K. Furthermore, the percent of polluted days directly correlates with Anti-dsDNA and NO2 significantly increases SLEQOL.

Conclusion: Based on our findings, air pollution (particularly NO2 and PM2.5) has affected at least some aspects of the disease and the health-related quality of life (HRQL) of lupus patients. Further research is needed to confirm these findings.

Graphical Abstract

[1]
Narayanan K, Marwaha V, Shanmuganandan K, Shankar S. Correlation between systemic lupus erythematosus disease activity index, C3, C4 and anti-dsDNA antibodies. Med J Armed Forces India 2010; 66(2): 102-7.
[http://dx.doi.org/10.1016/S0377-1237(10)80118-2] [PMID: 27365721]
[2]
Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol 1997; 145(5): 408-15.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a009122] [PMID: 9048514]
[3]
Ritz SA. Air pollution as a potential contributor to the ‘epidemic’ of autoimmune disease. Med Hypotheses 2010; 74(1): 110-7.
[http://dx.doi.org/10.1016/j.mehy.2009.07.033] [PMID: 19665849]
[4]
Miner JJ, Kim AHJ. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 2014; 40(1): 51-60.
[http://dx.doi.org/10.1016/j.rdc.2013.10.003] [PMID: 24268009]
[5]
Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 2015; 11(6): 329-41.
[http://dx.doi.org/10.1038/nrneph.2015.33] [PMID: 25825084]
[6]
Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anaemia in systemic lupus erythematosus: From pathophysiology to clinical assessment. Ann Rheum Dis 2006; 65(2): 144-8.
[http://dx.doi.org/10.1136/ard.2005.041673] [PMID: 16079164]
[7]
Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 2006; 15(5): 308-18.
[http://dx.doi.org/10.1191/0961203306lu2305xx] [PMID: 16761508]
[8]
Su DL, Lu ZM, Shen MN, Li X, Sun LY. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012; 2012: 1-15.
[http://dx.doi.org/10.1155/2012/347141] [PMID: 22500087]
[9]
Bernatsky S, Fournier M, Pineau CA, Clarke AE, Vinet E, Smargiassi A. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ Health Perspect 2011; 119(1): 45-9.
[http://dx.doi.org/10.1289/ehp.1002123] [PMID: 20870568]
[10]
Fernandes EC, Silva CA, Braga ALF, Sallum AME, Campos LMA, Farhat SCL. Exposure to air pollutants and disease activity in juvenile-onset systemic lupus erythematosus patients. Arthritis Care Res (Hoboken) 2015; 67(11): 1609-14.
[http://dx.doi.org/10.1002/acr.22603] [PMID: 25892357]
[11]
Makar M, Antonelli J, Di Q, Cutler D, Schwartz J, Dominici F. Estimating the causal effect of low levels of fine particulate matter on hospitalization. Epidemiology 2017; 28(5): 627-34.
[http://dx.doi.org/10.1097/EDE.0000000000000690] [PMID: 28768298]
[12]
Organization WH. The world health report 2002: Reducing risks, promoting healthy life: World Health Organization 2002. Available at: https://www.who.int/publications/i/item/9241562072
[13]
Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease: A statement for healthcare professionals from the expert panel on population and prevention science of the american heart association. Circulation 2004; 109(21): 2655-71.
[http://dx.doi.org/10.1161/01.CIR.0000128587.30041.C8] [PMID: 15173049]
[14]
Liu SK, Cai S, Chen Y, Xiao B, Chen P, Xiang XD. The effect of pollutional haze on pulmonary function. J Thorac Dis 2016; 8(1): E41-56.
[PMID: 26904252]
[15]
Valavanidis A, Fiotakis K, Vlachogianni T. Airborne particulate matter and human health: Toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 2008; 26(4): 339-62.
[http://dx.doi.org/10.1080/10590500802494538] [PMID: 19034792]
[16]
Pope CA III, Burnett RT, Thurston GD, et al. Cardiovascular mortality and long-term exposure to particulate air pollution: Epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004; 109(1): 71-7.
[http://dx.doi.org/10.1161/01.CIR.0000108927.80044.7F] [PMID: 14676145]
[17]
Ghio AJ, Carraway MS, Madden MC. Composition of air pollution particles and oxidative stress in cells, tissues, and living systems. J Toxicol Environ Health B Crit Rev 2012; 15(1): 1-21.
[http://dx.doi.org/10.1080/10937404.2012.632359] [PMID: 22202227]
[18]
Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64(8): 2677-86.
[http://dx.doi.org/10.1002/art.34473] [PMID: 22553077]
[19]
Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288-91.
[PMID: 11838846]
[20]
Leong KP, Kong KO, Thong BYH, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford) 2005; 44(10): 1267-76.
[http://dx.doi.org/10.1093/rheumatology/keh605] [PMID: 15797980]
[21]
Faustini A, Renzi M, Kirchmayer U, Balducci M, Davoli M, Forastiere F. Short-term exposure to air pollution might exacerbate autoimmune diseases. Environ Epidemiol 2018; 2(3): e025.
[http://dx.doi.org/10.1097/EE9.0000000000000025]
[22]
Jung CR, Chung WT, Chen WT, Lee RY, Hwang BF. Long-term exposure to traffic-related air pollution and systemic lupus erythematosus in Taiwan: A cohort study. Sci Total Environ 2019; 668: 342-9.
[http://dx.doi.org/10.1016/j.scitotenv.2019.03.018] [PMID: 30852211]
[23]
Alves AGF, de Azevedo Giacomin MF, Braga ALF, et al. Influence of air pollution on airway inflammation and disease activity in childhood-systemic lupus erythematosus. Clin Rheumatol 2018; 37(3): 683-90.
[http://dx.doi.org/10.1007/s10067-017-3893-1] [PMID: 29098476]
[24]
Bernatsky S, Smargiassi A, Barnabe C, et al. Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces. Environ Res 2016; 146: 85-91.
[http://dx.doi.org/10.1016/j.envres.2015.12.021] [PMID: 26724462]
[25]
Lanata C, Nayak R, Nitiham J, Taylor K, Barcellos L, Chung S, et al. Residential proximity to highways, dna methylation and systemic lupus erythematosus. Arthritis Rheumatol 2015; 67: 1604-5.
[26]
Gilcrease GW, Padovan D, Heffler E, et al. Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. Eur J Rheumatol 2020; 7(1): 31-4.
[http://dx.doi.org/10.5152/eurjrheum.2019.19141] [PMID: 32023206]
[27]
Organization WH. Fact sheet: Ambient (outdoor) air pollution: World Health Organization. 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health